Invention Grant
- Patent Title: Imidazotriazinecarbonitriles useful as kinase inhibitors
- Patent Title (中): 可用作激酶抑制剂的咪唑并三氮萘腈
-
Application No.: US14532218Application Date: 2014-11-04
-
Publication No.: US09556178B2Publication Date: 2017-01-31
- Inventor: Ashok Vinayak Purandare , Brian E. Fink , Ashvinikumar V. Gavai , Walter Lewis Johnson , Amy C. Hart , Liqi He , Tram N. Huynh , Jennifer Inghrim , Harold Mastalerz , Xiaopeng Sang , Christine M. Tarby , Honghe Wan , Wayne Vaccaro , Guifen Zhang , Yufen Zhao , Kurt Zimmermann
- Applicant: Bristol-Myers Squibb Company
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Elliott Korsen; Hong Liu
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D487/22 ; C07D403/04 ; A61K31/53 ; A61K31/5377 ; A61K31/5383 ; A61K31/551 ; A61K31/675 ; A61K45/06 ; C07D471/10 ; C07D487/10 ; C07D498/04 ; C07F9/6521 ; A61K31/541 ; A61K31/55 ; C07D487/08 ; C07D519/00 ; C07F9/6561 ; C07F7/18
Abstract:
The invention provides compounds of Formula (I) and pharmaceutically acceptable salts thereof. The Formula (I) imidazotriazines inhibit protein kinase activity thereby making them useful as anticancer agents.
Public/Granted literature
- US20150065465A1 IMIDAZOTRIAZINECARBONITRILES USEFUL AS KINASE INHIBITORS Public/Granted day:2015-03-05
Information query
